Featured on the back cover of Proteomics – Clinical Applications, Dr. Christoph Borchers’ newest publication focuses on the identification of biomarkers specific to coronary artery disease (CAD). Along with a group of BC scientists, including researchers from the University of Victoria and University of British Columbia, Dr. Borchers helped develop an LC-ESI-MS based assay that …
Dr. Britz-McKibbin, one of TMICs core-scientists, and his team at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs. The …
A recent study by TMIC’s Britz-McKibbin Research Group at McMaster University has identified new biomarkers for Irritable Bowel Syndrome (IBS) after comparing the metabolite profiles of urine samples from a cohort of IBS patients to a control group of healthy adults. Speaking on the study’s findings, lead author Dr. Philip Britz-McKibbin commented, “We were interested …
Targeted Metabolomics Identifies High Performing Diagnostic And Prognostic Biomarkers For Covid-19 When Dr. Yamile López-Hernández learned in early 2020 that the National Council of Science and Technology of Mexico (CONACYT) had issued a call for proposals for COVID-19-related research, one of the first people she reached out to was TMIC co-director Dr. David Wishart. While …
We request that any publications, posters, or oral presentations resulting from work performed by The Metabolomics Innovation Centre acknowledge TMIC. This allows the Centre to report information such as impact on Canadian researchers to our funding agencies. Clients should also keep us apprised of any publications, posters, or oral presentations arising from work performed at TMIC.
